Information Provided By:
Fly News Breaks for July 11, 2019
ANF, FCX, WW, WLTW, VEON
Jul 11, 2019 | 10:21 EDT
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Freeport McMoRan (FCX) upgraded to Buy from Hold at Deutsche Bank with analyst Chris Terry saying progress continues at Grasberg. 2. Veon (VEON) upgraded to Buy from Neutral at Goldman Sachs with analyst Vyacheslav Degtyarev saying the company's "strategic optionality" is not fully priced in at current share levels. 3. WW (WW) upgraded to Neutral from Underweight at JPMorgan with analyst Christina Brathwaite saying the company's subscriber trends have stabilized, which is supportive of its ability to reach 2019 guidance. 4. Abercrombie & Fitch (ANF) upgraded to Neutral from Underperform at Wedbush with analyst Jen Redding citing the stock's valuation reset. 5. Willis Towers Watson (WLTW) upgraded to Outperform from Market Perform at Wells Fargo with analyst Elyse Greenspan saying she sees a "strong set-up" into the company's Q2 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
News For FCX;VEON;WW;ANF;WLTW From the Last 2 Days
WW
Feb 25, 2020 | 19:05 EST
UP AFTER EARNINGS: Aclaris (ACRS) up 8.0%... WW International (WW) up 6.8%... Matador Resources (MTDR) up 6.0%... B&G Foods (BGS) up 5.7%... Alarm.com (ALRM) up 5.3%... Nevro (NVRO) up 3.4%... Infinera (INFN) up 3.4%... Evolent Health (EVH) up 3.1%... Paratek Pharma (PRTK) up 2.8%... Adamas Pharma (ADMS) up 1.9%... Akcea Therapeutics (AKCA) up 1.9%. DOWN AFTER EARNINGS: SmileDirectClub (SDC) down 20.5%... Revolve Group (RVLV) down 18.1%... Supernus Pharma (SUPN) down 15.0%... Insulet (PODD) down 12.1%... Southern Copper (SCCO) down 9.3%... Toll Brothers (TOL) down 9.0%... Vicor Corp (VICR) down 8.7%... Penumbra (PEN) down 6.9%... Unisys (UIS) down 6.1%... Planet Fitness (PLNT) down 5.9%... Virgin Galactic (SPCE) down 5.7%... RealReal (REAL) down 5.1%... Ormat Technologies (ORA) down 3.8%... Iovance Biotherapeutics (IOVA) down 3.1%... Exelixis (EXEL) down 3.1%... Evertec (EVTC) down 3.0%... Salesforce (CRM) down 2.1%... Jazz Pharma (JAZZ) down 1.8%... Caesars (CZR) down 1.6%... Amarin Corp (AMRN) down 1.4%... Red Robin (RRGB) down 1.3%. ALSO LOWER: Vanda Pharma (VNDA) down 7.6% after Phase 3 study of tradipitant did not meet primary endpoint... Disney (DIS) down 1.7% after naming new CEO. Movers as of 18:30ET.
WW
Feb 25, 2020 | 14:04 EST
Notable companies reporting after the market close, with earnings consensus, include Salesforce (CRM), consensus 55c... Alcon (ALC), consensus 46c... Caesars (CZR), consensus (11c)... Planet Fitness (PLNT), consensus 41c... Toll Brothers (TOL), consensus 45c... SmileDirectClub (SDC), consensus (9c)... WW International (WW), consensus 38c... Infinera (INFN), consensus (2c)... RealReal (REAL), consensus (19c).
WLTW
Feb 25, 2020 | 06:31 EST
Wells Fargo analyst Elyse Greenspan upgraded Aon plc (AON) to Overweight from Equal Weight with a price target of $265, up from $225. Aon is positioned to outperform as a standalone company or if it acquires Willis Towers Watson (WLTW), Greenspan tells investors in a research note. The analyst believes a standalone Aon is positioned to see "industry-leading" organic revenue growth and has "several tailwinds" to its free cash flow in 2020. If there is a deal, it would likely be because Aon believes it can pull a healthy level of expenses out of Willis without significant revenue disynergies, adds the analyst.